Opinions
Jim Cramer - Mad Money
Gritstone Oncology
GRTS-Q
COMMENT
Jan 20, 2021
A biotech that's up 342% in the past week, because yesterday they announced they're working on a 2nd-generation Covid vaccine. They already an agreement with the National Institute for Allergy and Infectious Diseases to start testing it. Their immunotherapy-based vaccine could be a game-changer even in phase 1 testing.
$25.490
Stock price when the opinion was issued
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising